Neuroscience Upper Rhine network
  • Login
  • Create my account
  • Home
  • About us
    • Neurex
    • Interneuron
    • Our partners
  • Events
    • Events to come
    • Archives
  • Research
    • By city
      • Strasbourg
      • Freiburg
      • Basel
    • By topic
  • Training
    • Joint Master in Neuroscience
    • MSc Neuroscience Freiburg
    • NeuroTime
    • EURIDOL
    • EuroSPIN
    • Challenge DDD
  • Consultancy
    • Our expertise
    • Our services
    • Our projects
  • Multimedia
  • Publications
    • Network Newsletter
    • General public Brochures
      • in French
      • in German
  • Jobs
    • Job offers
    • Submit your job offer

July 2020

Neurex newsletter n°35

  • Edito Covid 19 & neurosciences : an introduction
  • Report Viruses & nervous system disorders: insights from other pandemics
  • Report What about the neurological and psychiatric effects of SARS Cov2?
  • Report How coronaviruses gain entry into the nervous system
  • Report Viruses & Acute infections
  • Report Viruses & Alzheimer’s Disease
  • Report Viruses & Multiple Sclerosis
  • Report Viruses & Parkinson’s disease
  • Report Viruses & schizophrenia
  • Report Conclusion : SARS Cov2, a time bomb for neurological and psychiatric disease?
  • Info Legal info & links

Stys, P. K. and S. Tsutsui (2019). "Recent advances in understanding multiple sclerosis." F1000Res 8.

July 2020

Neurex newsletter n°35

Report

Viral infections, neurodegenerative & psychiatric diseases: an arduous search for clues …

Viral infections, neurodegenerative & psychiatric diseases: an arduous search for clues …

Viruses & Multiple Sclerosis

Data accumulate which highlight an important role of both autoimmune inflammation and progressive neurodegeneration in the pathophysiology of multiple sclerosis (MS). Despite an obvious success in reducing the burden of symptoms during relapses of the relapsing-remitting form of the disease (RRMS[1]), the clinical suppression of inflammation has however little to no effect on the progressive phase. The progressive component is a phase that either follows the earlier stage of RRMS or is immediately present at the onset of the disease in 15% of patients (PPMS[2]). Research data demonstrate a complex interplay between immunogenetics, environment, a neurodegenerative process underlying demyelination and a persistent innate inflammatory response that seems to increase as adaptive autoimmunity seems to fade (Stys and Tsutsui 2019). Interestingly, again, viruses have been suspected to play a role in the pathophysiology of Multiple Sclerosis, and in particular the Epstein Barr virus (EBV). Past exposure to the EBV is virtually a prerequisite for developing MS, while patients with symptomatic infection (mononucleosis) carry a higher risk of MS. However, the very high prevalence EBV exposure worldwide demonstrates that this factor is necessary but not sufficient to trigger MS. Does the EBV play a causative role or does it influence the secondary autoimmune response? Is that only one of the necessary factors in the chain of development of the disease? Clearly, much remains to be done but the encouraging data with a small cohort of patients treated with an EBV specific T cell therapy call for more research in this (viral) direction.

PP

 

[1] Relapsing Remitting Multiple Sclerosis [featured by relapses and remissions]

[2] Primary Progressive Multiple Sclerosis [featured by a steady decline of function without relapses and remissions]

 

Viruses & Parkinson’s disease

Parkinson’s Disease (PD) is a neurodegenerative disease caused by ... read more

Stys, P. K. and S. Tsutsui (2019). "Recent advances in understanding multiple sclerosis." F1000Res 8.

Small fond transparent.png

  • Interreg logo
  • Switzerland logo
  • European union logo

Cofinanced by the European Union / European regional
Development Fund (ERDF) Program Interreg V Upper Rhine
"Transcending borders with every project"

Copyright © 2025 www.neurex.org

  • Contact
  • Legal notice
  • Privacy policy
  • Cookies
  • Sitemap

Creation